Why is Pfizer's rollout of its anti-COVID pill so slow?

Pfizer's antiviral COVID-19 pill for at-risk people aged 12 and above has been authorised in the US.

Source: AAP

Pfizer's COVID-19 treatment pill Paxlovid was the first pill authorized in the U-S to treat coronavirus.But since its approval, there have been questions as to why it takes so long to make. While the time frame to make the pill isn't unusual, some are wondering if supplies will improve.



Share

Follow SBS Nepali

Download our apps

Listen to our podcasts

Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

Watch on SBS

Nepali News

Watch it onDemand

Watch now